Genome-Wide Association Studies Market Research Reveals Path To $4.25 Billion By 2030

The genome-wide association studies (GWAS) market is positioned for significant expansion in the coming years, driven by advancements in genomic research and growing healthcare needs. As precision medicine and genetic analytics gain prominence, this sector is attracting substantial investments and technological innovation. Here's an in-depth look at the market size, key players, emerging trends, and segmentation shaping the future of GWAS.

Projected Market Size of Genome-Wide Association Studies by 2030
The GWAS market is expected to experience rapid growth, reaching a value of $4.26 billion by 2030. This expansion corresponds to a compound annual growth rate (CAGR) of 13.4%. Factors contributing to this surge include increasing demand for precision medicine insights, rising investments in genomic analytics platforms, the growing role of AI in genetic research, heightened pharmaceutical focus on target discovery, and a stronger emphasis on predictive healthcare models. Notable trends during the forecast period encompass broader adoption of large-scale population genomics studies, enhanced use of advanced bioinformatics tools, deeper integration of GWAS in drug development, growth in personalized medicine research initiatives, and improved disease risk prediction capabilities.

The genome-wide association studies market size has grown rapidly in recent years. It will grow from $2.27 billion in 2025 to $2.58 billion in 2026 at a compound annual growth rate (CAGR) of 13.7%. The growth in the historic period can be attributed to expansion of genetic research initiatives, increasing availability of genomic datasets, growth in academic population studies, rising adoption of genotyping technologies, improvements in data analysis capabilities.

Download a free sample of the genome-wide association studies market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28234&type=smp&utm_source=Open&utm_medium=Paid&utm_campaign=Aug_PR

Leading Companies Driving the Genome-Wide Association Studies Market
The competitive landscape of the GWAS market features several prominent companies, including F. Hoffmann-La Roche AG, AstraZeneca plc, Thermo Fisher Scientific Inc., GlaxoSmithKline plc, Regeneron Pharmaceuticals Inc., Eurofins Scientific SE, Laboratory Corporation of America Holdings, Daiichi Sankyo Company Limited, Agilent Technologies Inc., Illumina Inc., Revvity Inc., QIAGEN N.V., Databricks Inc., Broad Institute of MIT and Harvard, BGI Genomics Co. Ltd., deCODE genetics Inc., Genomics England Ltd., CD Genomics Inc., Veritas Genetics Inc., Finngen, and The Wellcome Sanger Institute.

A notable development occurred in May 2025 when US-based Regeneron Pharmaceuticals acquired 23andMe Holding Co. for $256 million. This strategic acquisition enables Regeneron to leverage one of the largest consumer genetic databases to accelerate genomics-driven drug discovery, enhance precision medicine, and advance large-scale genetic research while upholding stringent data privacy and ethical guidelines. 23andMe, also a US biotechnology firm, specializes in genome-wide association studies.

View the full genome-wide association studies market report:
https://www.thebusinessresearchcompany.com/report/genome-wide-association-studies-global-market-report?utm_source=Open&utm_medium=Paid&utm_campaign=Aug_PR

Future Directions and Innovations in the Genome-Wide Association Studies Sector
Key players in the GWAS market are concentrating on the creation of innovative research platforms designed to expedite disease discovery and personalize medical applications. These advanced platforms combine multiple tools and technologies to facilitate the generation, analysis, and interpretation of large-scale genomic data essential for GWAS. For example, in January 2025, 23andMe launched Discover23, a consumer-focused platform offering genetic insights and ancestry exploration. This platform provides biopharma partners access to extensive genetic datasets within a secure environment powered by Lifebit. It includes analysis-ready GWAS data on over 1,000 disease cohorts, compiled from billions of phenotypic data points provided by millions of consenting participants. The platform's goal is to streamline drug discovery by uncovering novel disease mechanisms and potential therapeutic targets while supporting improved clinical trial outcomes and safeguarding participant privacy.

Segmentation Overview of the Global Genome-Wide Association Studies Market
This report segments the GWAS market into several categories:

1) Product Type:
- Genotyping Services
- Genotyping Kits and Reagents
- Software and Data Analysis Tools
- Other Product Types

2) Application:
- Drug Discovery
- Disease Risk Assessment
- Personalized Medicine
- Other Applications

3) End-User:
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Hospitals and Clinics
- Other End-Users

Further subcategories include:

- For Genotyping Services: Whole Genome Sequencing (WGS), Exome Sequencing, Targeted Genotyping
- For Genotyping Kits and Reagents: DNA Extraction Kits, Sequencing Reagents, Library Preparation Kits
- For Software and Data Analysis Tools: Bioinformatics Platforms, Data Visualization Tools, Statistical Analysis Software
- For Other Product Types: Sample Collection Devices, Quality Control Tools, Laboratory Consumables

This detailed segmentation highlights the various components and applications fueling the growth and diversification of the genome-wide association studies market globally.

New additions to our 2026 reports:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.